MedTrace Logo

BeauSaki Bird's Nest Peptide Efficacy

NCT07723508 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-07-23

No results posted yet for this study

Summary

The goal of this clinical trial is to learn whether BeauSaki Edible Bird's Nest Peptide Product can improve facial skin conditions in healthy adult participants. The main questions it aims to answer are:

Can daily intake of the edible bird's nest peptide product improve facial skin hydration, elasticity, brightness, wrinkles, pores, spots, redness, and skin texture after 8 weeks?

Is the edible bird's nest peptide product well tolerated by participants during the study period?

Researchers will compare participants who take the edible bird's nest peptide capsule with participants who take a placebo capsule without edible bird's nest to see if the product improves facial skin conditions.

Participants will:

* Take one capsule daily for 8 weeks.
* Visit the study site at baseline, week 4, and week 8 for non-invasive facial skin assessments.
* Cleanse their face with water and rest under room temperature conditions for 30 minutes before each skin assessment.
* Complete a brief questionnaire about perceived skin condition and product satisfaction at baseline, week 4, and week 8.
* Have facial photographs taken for skin condition evaluation, with identifiable areas masked before disclosure.

Conditions

  • Facial Skin Condition

Interventions

DIETARY_SUPPLEMENT

Placebo Capsule (matched dosing schedule)

Participants will take one placebo capsule without edible bird's nest daily for 8 weeks.

DIETARY_SUPPLEMENT

BeauSaki Edible Bird's Nest Peptide Product

Participants will take one capsule daily for 8 weeks.

Sponsors & Collaborators

  • Chia Nan University of Pharmacy ＆ Science

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2026-01-31
Completion
2026-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07723508 on ClinicalTrials.gov